392 related articles for article (PubMed ID: 7507795)
1. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
[TBL] [Abstract][Full Text] [Related]
2. Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.
Zhou ZW; Rieger N; Ruszkiewicz A; Wang GQ; Wan DS
World J Gastroenterol; 2005 Jun; 11(23):3640-3. PubMed ID: 15962393
[TBL] [Abstract][Full Text] [Related]
3. Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01.
Fisher ER; Colangelo L; Wieand S; Fisher B; Wolmark N
Dis Colon Rectum; 2003 Aug; 46(8):1021-5; discussion 1025-6. PubMed ID: 12907892
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study.
Adell G; Boeryd B; Frånlund B; Sjödahl R; Håkansson L
Eur J Surg; 1996 Aug; 162(8):637-42. PubMed ID: 8891622
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma.
Choi HJ; Choi YY; Hong SH
Dis Colon Rectum; 2002 Jun; 45(6):750-5; discussion755-6. PubMed ID: 12072625
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.
Jeffers MD; O'Dowd GM; Mulcahy H; Stagg M; O'Donoghue DP; Toner M
J Pathol; 1994 Feb; 172(2):183-7. PubMed ID: 7513353
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence.
Maehara Y; Oshiro T; Endo K; Baba H; Oda S; Ichiyoshi Y; Kohnoe S; Sugimachi K
Surgery; 1996 Apr; 119(4):397-402. PubMed ID: 8644003
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
Cote RJ; Houchens DP; Hitchcock CL; Saad AD; Nines RG; Greenson JK; Schneebaum S; Arnold MW; Martin EW
Cancer; 1996 Feb; 77(4):613-20. PubMed ID: 8616751
[TBL] [Abstract][Full Text] [Related]
9. The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome.
Clarke G; Ryan E; O'Keane JC; Crowe J; MacMathuna P
Eur J Gastroenterol Hepatol; 2000 May; 12(5):549-52. PubMed ID: 10833099
[TBL] [Abstract][Full Text] [Related]
10. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
11. Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer.
Mukai M; Sato S; Komatsu N; Nishida T; Shiba K; Ito I; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(5):1177-81. PubMed ID: 12883677
[TBL] [Abstract][Full Text] [Related]
12. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
13. Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer.
Mukai M; Sato S; Komatsu N; Nishida T; Shiba K; Ito I; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(5):1165-9. PubMed ID: 12883675
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2.
Isaka N; Nozue M; Doy M; Fukao K
Clin Cancer Res; 1999 Aug; 5(8):2065-8. PubMed ID: 10473087
[TBL] [Abstract][Full Text] [Related]
15. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer.
Davies M; Arumugam PJ; Shah VI; Watkins A; Roger Morgan A; Carr ND; Beynon J
Clin Transl Oncol; 2008 Mar; 10(3):175-9. PubMed ID: 18321821
[TBL] [Abstract][Full Text] [Related]
17. Detection of occult metastases in lymph nodes from patients with colorectal carcinoma by reverse transcriptase-polymerase chain reaction.
Liu Z; Ye X; Bi W; Wang M; Li Y; Chen T
Chin Med J (Engl); 2002 Apr; 115(4):529-31. PubMed ID: 12133290
[TBL] [Abstract][Full Text] [Related]
18. Identification of occult micrometastases in patients with early gastric cancer using anti-cytokeratin monoclonal antibodies.
Saragoni L; Gaudio M; Morgagni P; Folli S; Bazzocchi F; Scarpi E; Saragoni A
Oncol Rep; 2000; 7(3):535-9. PubMed ID: 10767364
[TBL] [Abstract][Full Text] [Related]
19. Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma.
Reggiani Bonetti L; Di Gregorio C; De Gaetani C; Pezzi A; Barresi G; Barresi V; Roncucci L; Ponz de Leon M
Scand J Gastroenterol; 2011 Jul; 46(7-8):881-6. PubMed ID: 21492052
[TBL] [Abstract][Full Text] [Related]
20. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma.
Haboubi NY; Clark P; Kaftan SM; Schofield PF
J R Soc Med; 1992 Jul; 85(7):386-8. PubMed ID: 1378498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
